Bristol-Myers Squibb has become the latest drugmaker in ... who source Eliquis only after they have bought the drug at normal commercial prices. In court documents, BMS' counsel asserts that ...
Bristol-Myers Squibb was founded in 1858 and has grown to be one of today's leading global pharmaceutical companies. For over 150 years, Bristol-Myers Squibb (BMS) has been committed to "discover ...
Hosted on MSN1d
Branded Pharmaceuticals Stocks Q4 In Review: Bristol-Myers Squibb (NYSE:BMY) Vs PeersQuarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
The U.S. drugmaker is turning to deals at a time when two of its top drugs, blood cancer treatment Revlimid and blood thinner Eliquis, face generic competition. Karuna’s crown jewel, an ...
FDA reform needs to be underpinned by strategy, not ‘indiscriminate’ cuts The Trump administration could save the lives of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results